Medical Research Commercialisation Fund IIF Overview
- Fund Strategy
-
Venture
- Fund Status
-
Closed
- Fund Manager
- Brandon Capital
- (You're viewing 1 of 2)
- Size
-
- Vintage
-
2011
- Dry Powder
-
Medical Research Commercialisation Fund IIF General Information
Description
Medical Research Commercialisation Fund IIF is a venture capital fund co-managed by Brandon Biocatalyst and Brandon Capital. The fund is located in Melbourne, Australia.
Contact Information
Fund Manager's Location
- Level 9
- 31 Queen Street
- Melbourne, Victoria 3000
- Australia
Medical Research Commercialisation Fund IIF Investments (8)
Medical Research Commercialisation Fund IIF has made a total of 8 investments. Its most recent deal was a with Vaxxas for . The deal was made on 09-Feb-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Vaxxas | 09-Feb-2015 | Drug Delivery | Clinical Trials - General | |||
| Vaxxas | 09-Feb-2015 | Drug Delivery | Clinical Trials - General | |||
| Q-Sera | 01-Jan-2015 | Medical Supplies | Generating Revenue | |||
| Heart Metabolics | 17-Apr-2014 | Diagnostic Equipment | Generating Revenue | |||
| Q-Sera | 18-Jun-2012 | Medical Supplies | Startup | |||
| GI Therapies | 01-Mar-2012 | Therapeutic Devices | Generating Revenue | |||
| Vaxxas | 01-Aug-2011 | Early Stage VC (Series A) | Drug Delivery | Startup | ||
| Otifex Therapeutics | 01-Dec-2010 | Seed Round | Drug Discovery | Startup |
Medical Research Commercialisation Fund IIF Investment Strategy
Medical Research Commercialisation Fund IIF Limited Partners (2)
AustralianSuper is one of Medical Research Commercialisation Fund IIF’s 2 limited partners. Its latest Original was on 01-Jan-2011.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| AustralianSuper | Current | 01-Jan-2011 | Original | ||
| Hostplus Superannuation Fund | Union Pension Fund | Current | 01-Jan-2011 | Original |
Medical Research Commercialisation Fund IIF Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
Medical Research Commercialisation Fund IIF Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Medical Research Commercialisation Fund IIF Benchmark (8)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Glilot Capital Partners | 30-Sep-2022 | ||||
| Jordan Growth Capital Fund | |||||
| DGF Early Stage 1 | |||||
| Digital Accelerator | |||||
| Digitalbusiness Portfolio III | |||||
| Catalyst Investments III | 30-Jun-2025 | ||||
| Pontifax Fund III | |||||
| Business Partners International Rwanda SME Fund |
Medical Research Commercialisation Fund IIF FAQs
-
What is Medical Research Commercialisation Fund IIF?
Medical Research Commercialisation Fund IIF is a venture capital fund co-managed by Brandon Biocatalyst and Brandon Capital.
-
Who manages Medical Research Commercialisation Fund IIF?
Medical Research Commercialisation Fund IIF is managed by Brandon Capital and Brandon Biocatalyst.
-
Where is Medical Research Commercialisation Fund IIF domiciled?
Medical Research Commercialisation Fund IIF is domiciled in Australia.
-
What is Medical Research Commercialisation Fund IIF's size?
Medical Research Commercialisation Fund IIF has a size of .
-
What type of fund is Medical Research Commercialisation Fund IIF?
The fund type of Medical Research Commercialisation Fund IIF is Venture.
-
What is the status of Medical Research Commercialisation Fund IIF?
Medical Research Commercialisation Fund IIF is closed.
-
What has Medical Research Commercialisation Fund IIF invested in?
Medical Research Commercialisation Fund IIF has made numerous investments in companies like Vaxxas, Q-Sera, and Heart Metabolics within the Drug Delivery, Medical Supplies, and Diagnostic Equipment industries.
-
What has Medical Research Commercialisation Fund IIF invested in recently?
Medical Research Commercialisation Fund IIF's latest investment was on 09-Feb-2015 in Vaxxas, a company within the Drug Delivery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process